Related references
Note: Only part of the references are listed.Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis
Tilmann Bochtler et al.
HAEMATOLOGICA (2008)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy
A. K. Stewart et al.
LEUKEMIA (2007)
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis
N. C. Gutierrez et al.
LEUKEMIA (2007)
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma
R. Fonseca et al.
LEUKEMIA (2006)
AL amyloidosis associated with B-cell lymphoproliferative disorders: Frequency and treatment outcomes
V. Sanchorawala et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation
Ichiro Hanamura et al.
BLOOD (2006)
Monoclonal gammopathy of undetermined significance
Robert A. Kyle et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and-17p13 in myeloma patients treated with high-dose therapy
MA Gertz et al.
BLOOD (2005)
Clinical outcomes in t(4;14) multiple myeloma: A chemotherapy-sensitive disease characterized by rapid relapse and alkylating agent resistance
W Jaksic et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics
FW Cremer et al.
GENES CHROMOSOMES & CANCER (2005)
A validated FISH trisony index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS
WJ Chng et al.
BLOOD (2005)
High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH
FW Cremer et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma
PL Bergsagel et al.
BLOOD (2005)
Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma
S Wuilleme et al.
LEUKEMIA (2005)
Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels
K Specht et al.
BLOOD (2004)
Maximum likelihood estimation of oncogenetic tree models
A Von Heydebreck et al.
BIOSTATISTICS (2004)
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
R Fonseca et al.
BLOOD (2003)
Molecular mechanisms of amyloidosis
G Merlini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL)
RS Abraham et al.
BLOOD (2003)
In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression
JJ Keats et al.
BLOOD (2003)
Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants
H Avet-Loiseau et al.
BLOOD (2003)
Analysis of Vλ-Jλ expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (λIII) as a new amyloid-associated germline gene segment
V Perfetti et al.
BLOOD (2002)
Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients
R Fonseca et al.
BLOOD (2002)
Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis
CJ Harrison et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation
H Avet-Loiseau et al.
BLOOD (2002)
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis
SR Hayman et al.
BLOOD (2001)
The tropism of organ involvement in primary systemic amyloidosis:: contributions of Ig VL germ line gene use and clonal plasma cell burden
RL Comenzo et al.
BLOOD (2001)
Translocation t(4;14)(p16.3;q32) is a recurrent genetic lesion in primary amyloidosis
V Perfetti et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
